US650760A - Gelatin capsule. - Google Patents

Gelatin capsule. Download PDF

Info

Publication number
US650760A
US650760A US73899399A US1899738993A US650760A US 650760 A US650760 A US 650760A US 73899399 A US73899399 A US 73899399A US 1899738993 A US1899738993 A US 1899738993A US 650760 A US650760 A US 650760A
Authority
US
United States
Prior art keywords
capsule
pepsin
gelatin
stomach
pill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US73899399A
Inventor
Frederick H Metcalf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US73899399A priority Critical patent/US650760A/en
Priority to US18307A priority patent/US671804A/en
Application granted granted Critical
Publication of US650760A publication Critical patent/US650760A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00Special receptacle or package
    • Y10S206/819Material

Definitions

  • ranonmcx 1-1 ranonmcx 1-1.
  • METCALF or FRANKLIN, ILLINOiS.
  • This invention relates to improvements in gelatin capsules and gelatin-coated pills and tablets, and has especial reference to capsules, increasing their solubility when used in connection with compounds which they incase.
  • the object of the invention is to provide a capsule and coating for pills which will be more soluble and susceptible to digestion when taken into the stomach than the ordinary capsule or gelatin-coated pill or tablet, as is now marketed.
  • the invention consists of mixing in the gelatin composition while it is in a liquid state a' sufficient quantity of pepsin or other drug which will assist the stomach to digest the capsule-shell or coating of pill or tablet.
  • Figure 1 is a section of the capsule.
  • Fig. 2 is a similar View showing the application of the invention to pills.
  • Fig. 3 is a sectional view of a capsule, showing another mode of applying my invention.
  • Fig. at is a sectional View of a further modification of a capsule.
  • FIG. 1 represents a capsule provided with a mixture of pepsin
  • Fig. 2 the invention is applied to a pill, the mode of operation and advantages obtained being substantially the same.
  • the mixture is first reduced by heat and water to a-liquid form and the composition thoroughly mixed. It is at this stage of the preparation of the composition that I put in a sufficient quantity of pepsin according to the intended purpose of the-capsule.
  • the same principle is em ployed.
  • the pill is prepared in the usual manner, after which it is rolled in a liquid composition of capsule-gelatin combined with pepsin, as before stated. I do not limit myself to the specific use of pepsin, as any analogous drug which can be mixed in with the composition without destroying or in any way affecting the gelatin can be substituted.
  • the invention is extremely simple and of great value where it is of absolute necessity in many cases that the medicine within the capsule should reach the stomach and act immediately.
  • the capsule-shell can be used to assist digestion a suflicient quantity of the pepsin having been mixed with the gelatin in its manufacture.
  • the walls of the capsule are made double and a layer of pepsin is interposed, and in Fig. 41- the construction is substantially the same, except that a small opening, 4 is provided in the outer capsule, so as to permit the juices in the stomach to immediately coact with the pepsin between the Walls.

Description

Patented May 29, I900.
F. H. METCALF.
GELAT-IN CAPSULE. (Applica tion filed Dec. 2, 1399.
(No Model.)
wwmm
5L4 JV M THE NORRXS PETERS CO, PNOYO-UTHO. WASHINGTON. n. C
Fries.
ranonmcx 1-1. METCALF, or FRANKLIN, ILLINOiS.
GELATIN CAPSU LE.
S PECIFICATION forming part of Letters Patent No. 650,760, dated May 29, 1900.
Application filed December 2, 18991 $erial No.'738;993. (No infidel.)
To all whom it may concern.-
Be it known that I FREDERICK H. CALF, a citizen of the United States, residing at Franklin, in the county of Morgan and State of Illinois, have invented new and useful Im provements in Capsules; of which the following is a specification.
This invention relates to improvements in gelatin capsules and gelatin-coated pills and tablets, and has especial reference to capsules, increasing their solubility when used in connection with compounds which they incase.
The object of the invention is to provide a capsule and coating for pills which will be more soluble and susceptible to digestion when taken into the stomach than the ordinary capsule or gelatin-coated pill or tablet, as is now marketed.
The invention consists of mixing in the gelatin composition while it is in a liquid state a' sufficient quantity of pepsin or other drug which will assist the stomach to digest the capsule-shell or coating of pill or tablet.
Many other objects and advantages will be hereinafter referred to, and particularly pointed out in the claim.
In the drawings forming a part of this specification, Figure 1 is a section of the capsule. Fig. 2 is a similar View showing the application of the invention to pills. Fig. 3 is a sectional view of a capsule, showing another mode of applying my invention. Fig. at is a sectional View of a further modification of a capsule.
In the drawings, 1 represents a capsule provided with a mixture of pepsin In Fig. 2 the invention is applied to a pill, the mode of operation and advantages obtained being substantially the same.
It is a well-known fact that frequently capsules are not easily digestible and under some circumstances tend to deter the quick and active operation of the medicine after it reaches the stomach. It is the purpose of this invention to assist the stomach in reducing the capsule-shell when it incases a compound or the coating of pill or tablet. The proportion of pepsin mixed with the capsule orcoating of pill or tablet when used for this purpose will be such as to not aifect the medicine contained within it, but to cowork with it. A
sufficient quantity is used to quickly and eliec= tually reduce the capsule-shell or coating of pill or tablet immediately after it is taken into the stomach, so as to expose the compound to the quick motion of the system to which and for which it was intended;
I propose to make a capsule especially pre} pared to contain compounds intended to aid digestion. For such purposes a greater quantity of pepsin will be added to the gelatin mixture than would otherwise be added when the capsules are to be used for ordinary purposes. In such cases the pepsin not only as sists the stomach to digest the capsule, but also acts in conjunction with the compound to accomplish its mission.
In the manufacture of gelatin capsules the mixture is first reduced by heat and water to a-liquid form and the composition thoroughly mixed. It is at this stage of the preparation of the composition that I put in a sufficient quantity of pepsin according to the intended purpose of the-capsule. In applying the improvement to pills the same principle is em ployed. The pill is prepared in the usual manner, after which it is rolled in a liquid composition of capsule-gelatin combined with pepsin, as before stated. I do not limit myself to the specific use of pepsin, as any analogous drug which can be mixed in with the composition without destroying or in any way affecting the gelatin can be substituted.
, It will be seen that the invention is extremely simple and of great value where it is of absolute necessity in many cases that the medicine within the capsule should reach the stomach and act immediately. By mixing the pepsin in the composition as above described I have not only produced a novel means of assisting nature, but have provided something which can be produced cheaply and at the same time have not added any thing to the weight of the capsule-shell, nor have I mixed a drug with the gelatin which will in any way destroy any element of the composition.
In many cases the capsule-shell can be used to assist digestion a suflicient quantity of the pepsin having been mixed with the gelatin in its manufacture.
As shown in Fig. 3 the walls of the capsule are made double and a layer of pepsin is interposed, and in Fig. 41- the construction is substantially the same, except that a small opening, 4 is provided in the outer capsule, so as to permit the juices in the stomach to immediately coact with the pepsin between the Walls.
' Having thus described my invention, What I claim is- As an article of man u facture, a gelatin capsule having pepsin incorporated with its 00111' to position, as set forth.
In testimony whereof I have hereunto set my hand in the presence of two subscribing witnesses.
FREDERICK H. MEICALF.
\Vitnesses:
OHAs. A. BARNES, LENA C. ENGEL.
US73899399A 1899-12-02 1899-12-02 Gelatin capsule. Expired - Lifetime US650760A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US73899399A US650760A (en) 1899-12-02 1899-12-02 Gelatin capsule.
US18307A US671804A (en) 1899-12-02 1900-05-28 Coated pill, &c.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73899399A US650760A (en) 1899-12-02 1899-12-02 Gelatin capsule.

Publications (1)

Publication Number Publication Date
US650760A true US650760A (en) 1900-05-29

Family

ID=2719330

Family Applications (1)

Application Number Title Priority Date Filing Date
US73899399A Expired - Lifetime US650760A (en) 1899-12-02 1899-12-02 Gelatin capsule.

Country Status (1)

Country Link
US (1) US650760A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2911338A (en) * 1954-03-09 1959-11-03 Abbott Lab Capsules and method of producing
US3285408A (en) * 1964-10-16 1966-11-15 Lilly Co Eli Capsule with integral locking band
US3403106A (en) * 1965-07-12 1968-09-24 Armour & Co Buoyant soap cake and preparation thereof
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
US3639259A (en) * 1969-04-09 1972-02-01 Ncr Co Enzymatic treatment of gelled proteinaceous film material
US3943238A (en) * 1972-11-01 1976-03-09 Meija Seika Co., Ltd. Method for the preparation of medicinal capsules
US4115534A (en) * 1976-08-19 1978-09-19 Minnesota Mining And Manufacturing Company In vitro diagnostic test
US4169804A (en) * 1976-08-19 1979-10-02 Minnesota Mining And Manufacturing Company Magnetically responsive composite microparticle
US4261969A (en) * 1979-05-03 1981-04-14 World Health Organization Controlled drug release composition
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
US5750145A (en) * 1995-07-28 1998-05-12 Bristol-Myers Squibb Company Stable gelatin coated aspirin tablets

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2911338A (en) * 1954-03-09 1959-11-03 Abbott Lab Capsules and method of producing
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
US3285408A (en) * 1964-10-16 1966-11-15 Lilly Co Eli Capsule with integral locking band
US3403106A (en) * 1965-07-12 1968-09-24 Armour & Co Buoyant soap cake and preparation thereof
US3639259A (en) * 1969-04-09 1972-02-01 Ncr Co Enzymatic treatment of gelled proteinaceous film material
US3943238A (en) * 1972-11-01 1976-03-09 Meija Seika Co., Ltd. Method for the preparation of medicinal capsules
US4115534A (en) * 1976-08-19 1978-09-19 Minnesota Mining And Manufacturing Company In vitro diagnostic test
US4169804A (en) * 1976-08-19 1979-10-02 Minnesota Mining And Manufacturing Company Magnetically responsive composite microparticle
US4261969A (en) * 1979-05-03 1981-04-14 World Health Organization Controlled drug release composition
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
US5750145A (en) * 1995-07-28 1998-05-12 Bristol-Myers Squibb Company Stable gelatin coated aspirin tablets

Similar Documents

Publication Publication Date Title
US650760A (en) Gelatin capsule.
US710060A (en) Capsule for medicines.
US671804A (en) Coated pill, &c.
GB191300392A (en) Medicinal Preparation in Tablet Form.
US1746984A (en) Vehicle for acetyl-salicylic acid tablets
US2870060A (en) Stable encapsulated solution of a salt of a dialkyl sulfosuccinate
US1021674A (en) Medicinal tablet.
US279166A (en) William huffman
US132275A (en) Improvement in medical compounds
US206676A (en) Improvement in medical compounds
US152327A (en) Improvement in medical compounds
USD50538S (en) Design foe a candy tablet
US294687A (en) Medical compound
USD43263S (en) Design foe an advebtising-sign structure
US266778A (en) Ments
Velasquez et al. Precipitous resolution of type-A intramural hematoma with medical management in a patient with metastatic stage 4 renal cell carcinoma
US102788A (en) Improved medical compound
US57561A (en) Improved medicine
USD52688S (en) Design for
AT35705B (en) Process for the production of easily soluble gelatin capsules.
Kulkarni Clopidogrel in cardiovascular disorders
US327233A (en) caenrick
US192590A (en) In hog-cholera compounds
USD49123S (en) Design for a bottle-stopper
US54492A (en) Improved compound sirup